Copyright
©2010 Baishideng.
World J Gastroenterol. May 14, 2010; 16(18): 2227-2234
Published online May 14, 2010. doi: 10.3748/wjg.v16.i18.2227
Published online May 14, 2010. doi: 10.3748/wjg.v16.i18.2227
Etiology | MARS treatment initiation criteria | Treatment protocol |
Acute liver failure | Rapid deterioration of hepatic synthetic function and clinical condition despite conservative standard medical therapy | 22-h sessions daily until: |
And one of the following criteria: | (1) Native liver recovers | |
(1) Ingestion of a lethal dose of a known hepatotoxin (e.g. Amanita, paracetamol) | (2) Suitable transplant organ is found | |
(2) The patient fulfills the criteria for highly urgent liver transplantation | (3) Irreversible multi-organ damage occurs |
- Citation: Kantola T, Mäklin S, Koivusalo AM, Räsänen P, Rissanen A, Roine R, Sintonen H, Höckerstedt K, Isoniemi H. Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure. World J Gastroenterol 2010; 16(18): 2227-2234
- URL: https://www.wjgnet.com/1007-9327/full/v16/i18/2227.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i18.2227